Publication | Closed Access

Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat

Medroxyprogesterone AcetateBreast OncologyOncologyMedicineMammary CarcinomaBreast CancerPure Antiestrogen Em-219Anti-cancer AgentPharmacologyRadiation OncologyOvarian HormoneCancer ResearchEndocrine-related Cancer